Find out more about Regener-Eyes® first in class biologic eye drop with anti-inflammatory cytokines and growth factors, with the manufacturer’s Founder, Chairman, and CEO C. Randall Harrell, MD. The drop is made with the company’s d-MAPPS™ (derived–Multiple Allogeneic Proteins Paracrine Signaling) platform technology engineered to stimulate […]

Words matter! In this episode, Drs. Craig and Nelson describe the hurdles TFOS faced in arriving at the definition and the classification of dry eye disease. The group understood that revising the definition would require extremely care as it was to set the tone for […]

Dr. Sullivan returns for Part 2 of the History of TFOS. Here he discusses embarking on the work that would become TFOS DEWS 2, the International Workshop on Meibomian Gland Dysfunction, and current research on the adverse ocular effects of many of the ingredients commonly […]

Part 1 of this 2-part episode offers a rare peek behind the curtain with David Sullivan, MD, of Schepens Eye Research Institute and Harvard Medical School. Dr. Sullivan is the Founder, recent President, and current Chairman of the Board of Directors of the Tear Film […]